ARRANON (GlaxoSmithKline LLC)
Welcome to the PulseAid listing for the ARRANON drug offered from GlaxoSmithKline LLC. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | GlaxoSmithKline LLC |
| NON-PROPRIETARY NAME: | nelarabine |
| SUBSTANCE NAME: | NELARABINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2006-01-19 |
| END MARKETING DATE: | 2018-12-31 |
ARRANON HUMAN PRESCRIPTION DRUG Details:
| Item Description | ARRANON from GlaxoSmithKline LLC |
| LABELER NAME: | GlaxoSmithKline LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/mL) |
| START MARKETING DATE: | 2006-01-19 |
| END MARKETING DATE: | 2018-12-31 |
| PRODUCT ID: | 0007-4401_22b8c921-10d4-4a4f-9811-384d2b98853b |
| PRODUCT NDC: | 0007-4401 |
| APPLICATION NUMBER: | NDA021877 |
Other NELARABINE Pharmaceutical Manufacturers / Labelers:
